For FY26, Sharda Cropchem aims to grow its topline by 15% while maintaining healthy EBITDA Margins in the range of 15-18%. Previous Post Silver beats gold in recent rally: Should you buy the white metal now Next Post Cipla Q1 Results: Stock surges after US sales, margins beat expectations Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment